DekaBank Deutsche Girozentrale - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2016$172,000
-20.7%
39,000
-6.0%
0.00%0.0%
Q4 2015$217,000
-11.4%
41,500
+2.5%
0.00%
-33.3%
Q3 2015$245,000
-59.5%
40,500
+5.7%
0.00%
-57.1%
Q2 2015$605,000
+72.4%
38,300
+18.6%
0.01%
+75.0%
Q1 2015$351,000
-0.8%
32,300
-4.2%
0.00%0.0%
Q4 2014$354,000
+0.6%
33,700
-8.2%
0.00%
-20.0%
Q3 2014$352,000
-14.6%
36,700
+2.8%
0.01%
-16.7%
Q2 2014$412,000
+13.8%
35,700
-1.4%
0.01%0.0%
Q1 2014$362,000
-23.8%
36,200
+6.5%
0.01%
-25.0%
Q4 2013$475,000
+2.6%
34,000
+9.7%
0.01%0.0%
Q3 2013$463,000
+79.5%
31,000
+12.7%
0.01%
+60.0%
Q2 2013$258,00027,5000.01%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2015
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders